Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2 (mars 2014) (CSS 9138)
-
-
Advies 9138 - 223RACL2
Dutchhgr_9138_advies_223racl2.pdf PDF document - 440.47 KB -
Avis 9138 - Radionuclide Therapy for Symptomatic Prostate Cancer in Castration-Resistant Prostate Cancer Patients with 223RaCl2
Frenchcss_9138_avis_223racl2.pdf PDF document - 410.98 KB